ReConstruct

CollPlant and Stratasys Launch Pre-clinical Trial for Regenerative 3D-Printed Breast Implants

Stratasys (Nasdaq: SSYS) and CollPlant Biotechnologies (Nasdaq: CLGN) are working together on a new type of 3D printed breast implant that could be a game-changer for patients. These implants, made…

Featured

Boston’s Additive Edge: Wyss Institute’s New Spin-Out Advances Natural Breast Reconstruction

“Women who survive breast cancer are often left with inadequate reconstruction choices—synthetic implants that can fail, cause additional cancers and leave them in constant discomfort; or complex surgeries that can…